Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imaging Non-motor Symptoms of PD with 18F-DTBZ and Florbetapir PET
NCT02039024Phase 2Completed
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Mar 2012
- Primary completion
- Dec 2015
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial, sponsored by Chang Gung Memorial Hospital. Primary endpoints: Amyloid deposition of brain by florbetapir F-18 PET imaging at 3 years and Monoaminergic function by 18F-DTBZ PET at 3 years. Started Mar 2012; status: completed.
Beyond the preview
Go deeper on NCT02039024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02039024.